Marina Rode von Essen

7PUBLICATIONS
20CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 09, 2024
CD11c+ B cells in relapsing-remitting multiple sclerosis and effects of anti-CD20 therapy.

Sahla El Mahdaoui, Marie Mathilde Hansen, Marina Rode von Essen

|Jun 27, 2023
Intrathecal CD8+CD20+ T Cells in Primary Progressive Multiple Sclerosis.

Marina Rode von Essen, Jacob Talbot, Rikke Holm Holm Hansen

|May 16, 2023
Cladribine Effects on T and B Cells and T Cell Reactivity in Multiple Sclerosis.

Rikke Holm Hansen, Marina Rode von Essen, Mie Reith Mahler

|Jul 14, 2022
Increased Intrathecal Activity of Follicular Helper T Cells in Patients With Relapsing-Remitting Multiple Sclerosis.

Rikke Holm Hansen, Jacob Talbot, Helene Højsgaard Chow

|Jun 07, 2022
Ofatumumab Modulates Inflammatory T Cell Responses and Migratory Potential in Patients With Multiple Sclerosis.

Marina Rode von Essen, Rikke Holm Hansen, Camilla Højgaard

|Aug 25, 2021
Dimethyl Fumarate Treatment in Patients With Primary Progressive Multiple Sclerosis: A Randomized, Controlled Trial.

Helene Højsgaard Chow, Jacob Talbot, Henrik Lundell

Pageof 2